| Dr Seyyedhossein Mousavi, | |
|
22030 Sherman Way Ste 219, Canoga Park, CA 91303-1855 | |
| (424) 644-1646 | |
| Not Available |
| Full Name | Dr Seyyedhossein Mousavi |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 22030 Sherman Way Ste 219, Canoga Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033625181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 102218 (California) | Secondary |
| 122300000X | Dentist | 102218 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seyyedhossein Mousavi, 45377 Palmwood Dr, Indio, CA 92201-5112 Ph: () - | Dr Seyyedhossein Mousavi, 22030 Sherman Way Ste 219, Canoga Park, CA 91303-1855 Ph: (424) 644-1646 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
Celldex Therapeutics, Inc. today announced that mature results from a Phase 1/2 study evaluating CDX-011 in advanced stage breast cancer patients were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). CDX-011 is an experimental antibody-drug conjugate (ADC) directed against glycoprotein NMB (GPNMB) and linked to a potent cancer cell-killing drug, monomethyl-auristatin E (MMAE).
Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.
Prostate cancer kills more African-American and black men than any other group. Yet, according to a new review published by Moffitt Cancer Center researchers, there is a significant lack of clear and consistent screening and early detection guidelines or prevention strategies.
Researchers from Case Western Reserve University are teaming with industry and other academics to develop a quick and inexpensive test to predict which women with ER+ breast cancer need chemotherapy and which need only the more tolerable hormonal therapy.
› Verified 9 days ago
Dr. Hoi S Yueung, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 8925 De Soto Ave, Canoga Park, CA 91304 Phone: 818-882-1881 Fax: 818-882-7881 | |
Dr. Ziad G. Rhayem, Dentist Medicare: Not Enrolled in Medicare Practice Location: 21123 Victory Blvd, Canoga Park, CA 91303 Phone: 818-888-2700 Fax: 818-888-8317 | |
Menachem Oren, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 21123 Victory Blvd, Canoga Park, CA 91303 Phone: 818-888-2700 Fax: 818-888-8317 | |
Dr. Kambiz Kalai, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6832 Desoto Ave, Canoga Park, CA 91303 Phone: 818-888-2211 Fax: 818-888-2925 | |
Raffi John Maronian, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 8358 Topanga Canyon Blvd, Canoga Park, CA 91304 Phone: 818-348-8400 Fax: 818-348-4040 | |
Ramya Chelimela, Dentist Medicare: Medicare Enrolled Practice Location: 21126 Ingomar Ct, Canoga Park, CA 91304 Phone: 510-676-4948 |